US EditionHealth Canada approves epinephrine nasal spray for anaphylaxis
The two-milligram dose is approved for adults and children weighing at least 30 kilograms, and pharmacies nationwide could stock it this summer.
- Health Canada approved Neffy on Wednesday, the country's first needle-free nasal spray for severe allergic reactions caused by insect stings, bites, foods, and medications.
- Current emergency treatment relies solely on EpiPens, single-use devices injecting epinephrine into muscle. Research shows half of those with life-threatening allergies fail to carry or use prescribed auto-injectors when needed.
- Distributor ALK Canada confirmed the two-milligram spray is approved for adults and pediatric patients weighing at least 30 kilograms, roughly 66 lbs. An estimated 2.5 million Canadians have severe allergies.
- The spray features a 30-month shelf life and requires no special storage, ALK Canada says. The company expects the product available in pharmacies nationwide as soon as this summer.
- Food Allergy Canada applauded the approval as "an important step forward" for patient choice. The United States approved Neffy in summer 2024, though that market also offers a one-milligram dosage for children.
40 Articles
40 Articles
Health Canada Approves Nasal Epinephrine as Treatment for Anaphylaxis
The first needle-free epinephrine treatment for severe allergic reactions has received approval from Health Canada. An epinephrine auto-injector, better known by the brand name EpiPen, is the only emergency treatment option currently on the market in Canada for allergic reactions. But that is expected to change within the next few months. Neffy, a two-milligram nasal spray treatment, has been approved by the government agency for use by adults a…
Waterloo Chronicle
Afraid of needles? Canada approves first epinephrine nasal spray for treating severe allergies
Emergency antidote “neffy” is a needle-free epinephrine nasal spray for people with potentially fatal food, insect stings and medicinal allergies expected to be available in pharmacies across Canada starting in summer 2026.
Health Canada approved the first needle-free treatment for severe allergic reactions: a nasal spray called Neffy.
Bowen Island Undercurrent
Meet neffy: Health Canada approves epinephrine nasal spray for anaphylaxis
Coverage Details
Bias Distribution
- 81% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
